Skip to main content
DBD
NYSE Technology

Capital World Investors' Diebold Nixdorf Stake Climbs to 34.9% as Share Count Contracts

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
7
Price
$73.93
Mkt Cap
$2.498B
52W Low
$53.93
52W High
$92.085
52W Position info
37% above low
Off High info
20% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

DBD sits 37% above its 52-week low of $53.93.

Summary

Capital World Investors' stake in Diebold Nixdorf rose to 34.9% from 33.3% after the company's share count declined, giving the fund greater proportional control without additional buying.


Key Events · Ownership and Investor Activity · DBD

  • Ownership Stake Rises to 34.9%

    Capital World Investors now holds 11,844,145 shares, representing 34.9% of Diebold Nixdorf's outstanding common shares, up from 33.3% previously.

  • Share Count Reduction Drives Increase

    The percentage increase is due to a decrease in total outstanding shares from 35.6 million to 33.9 million, as reported in the Q2 2026 10-Q, rather than new purchases by the fund.

  • Passive Concentration Amplifies Influence

    With no additional buying, the fund's voting power has grown, potentially giving it greater sway over corporate decisions and reflecting confidence in the company's recent performance.

  • Context: Strong Q2 Results Precede Filing

    This filing comes two days after Diebold Nixdorf reported Q2 2026 revenue of $930.8M (up 1.7% YoY) and adjusted EBITDA of $120.6M (up 8%), reinforcing positive momentum.


Analysis · DBD · Technology

A shrinking share base has lifted Capital World Investors' ownership in Diebold Nixdorf to 34.9% from 33.3%, even without additional purchases. The company's total shares outstanding fell from 35.6 million to 33.9 million—likely reflecting buybacks—which passively concentrates the fund's influence and signals conviction in the firm's trajectory, particularly on the heels of robust Q2 results. That said, a thinner float could also heighten stock volatility.

At the time of this filing, DBD was trading at $73.93 on NYSE in the Technology sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $53.93 to $92.09. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DBD - Latest Insights

DBD
Jul 29, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $75.17
Real-time Price: $73.93 info
Change: -$1.24 (-2%) info
Market Cap: $2.498B info
DBD
Jul 29, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $90.75
Real-time Price: $73.93 info
Change: -$16.82 (-19%) info
Market Cap: $2.498B info
DBD
Jun 26, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $84.98
Real-time Price: $73.93 info
Change: -$11.05 (-13%) info
Market Cap: $2.498B info
DBD
Apr 30, 2026, 7:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.50
Real-time Price: $73.93 info
Change: -$8.57 (-10%) info
Market Cap: $2.498B info
DBD
Apr 17, 2026, 4:28 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $88.60
Real-time Price: $73.93 info
Change: -$14.67 (-17%) info
Market Cap: $2.498B info